Meeting ReportMolecular Targeting Probes-Radioactive & Nonradioactive - Preclinical Probes for Oncology
Adaptation of the Antibody-Drug Conjugate PADCEV into an ImmunoPET Agent Against Nectin-4
Tullio V Esposito, Kali Jones, Ali Mouzannar, Jacob Tallman, Paula Demetrio De Souza Franca, Teja Kalidindi, Alvin Goh and Naga Vara Kishore Pillarsetty
Journal of Nuclear Medicine June 2024, 65 (supplement 2) 242152;
Tullio V Esposito
1Memorial Sloan-Kettering Cancer Center (MSKCC)
Kali Jones
2Memorial Sloan Kettering Cancer Center (MSKCC)
Ali Mouzannar
2Memorial Sloan Kettering Cancer Center (MSKCC)
Jacob Tallman
2Memorial Sloan Kettering Cancer Center (MSKCC)
Paula Demetrio De Souza Franca
3University of Wisconsin-Madison
Teja Kalidindi
4Memorial Sloan Kettering Cancer Center
Alvin Goh
2Memorial Sloan Kettering Cancer Center (MSKCC)
Naga Vara Kishore Pillarsetty
4Memorial Sloan Kettering Cancer Center

Article Figures & Data
In this issue
Journal of Nuclear Medicine
Vol. 65, Issue supplement 2
June 1, 2024
Adaptation of the Antibody-Drug Conjugate PADCEV into an ImmunoPET Agent Against Nectin-4
Tullio V Esposito, Kali Jones, Ali Mouzannar, Jacob Tallman, Paula Demetrio De Souza Franca, Teja Kalidindi, Alvin Goh, Naga Vara Kishore Pillarsetty
Journal of Nuclear Medicine Jun 2024, 65 (supplement 2) 242152;
Adaptation of the Antibody-Drug Conjugate PADCEV into an ImmunoPET Agent Against Nectin-4
Tullio V Esposito, Kali Jones, Ali Mouzannar, Jacob Tallman, Paula Demetrio De Souza Franca, Teja Kalidindi, Alvin Goh, Naga Vara Kishore Pillarsetty
Journal of Nuclear Medicine Jun 2024, 65 (supplement 2) 242152;
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.